Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Gador S.A.

Internet and e-mail are magic words in communication.Recombinant protein, monoclonal antibody and gene therapy are a few expressions which witness the progress of health sciences.True to its mission, Gador has actively participated in bringing new knowledge to daily life for more than half a century.By means of Gador's own research, high-quality and price-conscious drugs have been developed. Today, we continue to work with the same will, constantly devoted to the improvement of health. We are pleased to convey through the Internet detailed and objective data about Gador and its line of products. It reflects the image of a company sensitive to changes and aimed at the future, which strengthens the confidence among professionals and patients. With a help of the Internet we will navigate through this information together.


Contact Details:
Darwin 429
Buenos Aires
1414
Argentina
Tel:(54-11) 4858-9000
Fax:
Email:info@gador.com.ar
WWW:

www.gador.com.ar/




BioNews Results for Gador S.A.:

Genetic Polymorphism and Major Depression: New Theories
Consultant Live:  Nov 15 2009 7:17PM Matching: s
A pandemic response to a disease of predominantly seasonal intensity - 16 November 2009
The Medical Journal of Australia:  Nov 15 2009 3:10PM Matching: s
Schmid M, Egli K, Martin BW, Bauer G. Health promotion in primary care: evaluation of a systematic procedure a
Swiss Medical Weekly:  Nov 14 2009 10:06PM Matching: s
Cook S, Windecker S. Revascularisation of coronary artery disease in patients with diabetes mellitus [654]
Swiss Medical Weekly:  Nov 14 2009 10:07PM Matching: s
Apoptosis Cell Biology: Scientists at University of Lausanne, Center for Integrative Genomics detail research in apoptosis cell biology
NewsRX:  Nov 14 2009 6:48AM Matching: s
Promote your company here: BioNewsCast - Press Release Distribution

View more Gador S.A. news.

Gador S.A. Patents:

US Patent No.Title
7560490 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
7345183 Process for obtaining norelgestromin in different relations of isomers E and Z
6864228 Use of bisphosphonates for the treatment of osteogenesis imperfecta
6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
5990098 Therapeutic use of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid and its salts

View more Gador S.A. patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 525 times since April 2007, the link to the organisation's website has been followed 62 times

Recent Search Terms used to find this page: Gador S.A. Darwin 429 1414 4858-9000 | Gador S A | gador S. A. | GADOR | gador s.a | argentina gador distributor | gador distributors- argentina | Gador SA | GIDOR SA email | .

Search for more companies in Buenos Aires

Search for more companies in



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Gador S.A.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.